Free Communication 7 - PCOS
Tracks
Meeting Room 6 (Secretariat Building Level 2)
| Friday, May 24, 2024 |
| 3:15 PM - 4:45 PM |
Overview
Chairs:
Madhuri Patil (India)
Robert Lahoud (Australia)
------------
Presentation Paper #
#24 (PCOS)
#56 (PCOS)
#141 (PCOS)
#145 (PCOS)
#147 (PCOS)
#168 (PCOS)
#216 (PCOS)
Speaker
Dr. Ruimin Zhao
MD
Zhejiang University
Overweight and obesity determined by body mass index criteria for Asian populations adversely affect assisted reproductive outcomes among Chinese women with polycystic ovary syndrome
Dr. Qi Cao
Research Associate
West China Second University Hospital, Sichuan University
THE EARLY DEVELOPMENT OF OFFSPRING FROM WOMEN WITH POLYCYSTIC OVARY SYNDROME: PROSPECTIVE COHORT STUDY FROM CHINA
Mr. Gezta Nasafir Hermawan
Obstetrics and Gynecology Resident
Kandou Central General Hospital – Faculty of Medicine Universitas Sam Ratulangi
NOVEL GLP-1 RECEPTOR AGONIST PLUS METFORMIN REGIMEN FOR ASIAN POLYCYSTIC OVARY SYNDROME PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF EFFICACY AND SAFETY
Dr. Luyang Zha
Doctor Of Medicine
Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology
POLYCYSTIC OVARY SYNDROME AND PHYSICAL ACTIVITY: A BIDIRECTIONAL TWO-SAMPLE MENDELIAN RANDOMIZATION STUDY
Mr. Muhammad Ikhsan
Fellow
Faculty Of Medicine Universitas Indonesia
LEAN POLYCYSTIC OVARIAN SYNDROME (PCOS) HAS BETTER RESPONSES TO RECOMBINANT FOLLICLE-STIMULATING HORMONE COMPARED TO OBESE PCOS DURING OVARIAN STIMULATION FOR IN VITRO FERTILIZATION
Dr. Rohina Gul
Fertility Consultant
Hameed Latif Hospital
COMPARISON OF OOCYTE MATURATION IN GNRH-ANTAGONIST PROTOCOL TRIGGER BY HCG OR GNRH-AGONIST IN PCOS PATIENTS
Mr. Yuya Makino
Kitakyushu, Fukuoka, JAPAN
Saint Mother Hospital
Combined use of Letrozole, Cabergoline and GnRH antagonist to prevent ovarian hyperstimulation syndrome completely in polycystic ovarian syndrome treatment.
